Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

bioMerieux UK launches Staphylococcus assay:

This article was originally published in Clinica

Executive Summary

bioMerieux UK has launched a latex agglutination assay for Staphylococcus aureus. The assay, called Slidex Staph Plus, offers 97.6% sensitivity to methicillin resistant and 98.5% sensitivity to methicillin resistant and methicillin sensitive strains combined. Slidex Staph Plus detects clumping factor, the body's immune response to infection as well as protein A and peripheral and capsular antigens. Positive samples form thick agglutinates within 30 seconds.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel